Journal of Neuro-Oncology

, Volume 40, Issue 2, pp 151–160 | Cite as

Brain tumor survival: Results from the National Cancer Data Base

  • Tanya S. Surawicz
  • Faith Davis
  • Sally Freels
  • Edward R. LawsJr.
  • Herman R. Menck


Hospital-based data reported to the National Cancer Data Base (NCDB) were available for over 60,000 patients with a primary brain tumor diagnosed from 1985–1988 and 1990–1992. The most common histologies were glioblastomas, astrocytomas and meningiomas. Five-year survival rates for these tumors were 2%, 30% and 70% respectively. Histology, age at diagnosis, behavior, and location were important variables in estimating survival. Comparisons with population-based registry data suggest that the malignant tumors are well represented in NCDB, but the benign histologies are under-reported. Survival estimates for the malignant tumors are comparable to previously reported studies. The NCDB provides recent information on brain tumor distribution and survival patterns not available in other large databases.

survival brain tumors epidemiology 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kosary CL, Ries LAG, Miller BA, Hankey BF, Harras A, Edwards BK (eds): SEER cancer statistics review, 1973–1992: tables and graphs. NIH Pub. No. 96-2789. Natl Canc Inst, Bethesda, MD, 1995Google Scholar
  2. 2.
    Mahaley MS, Mettlin C, Natarajan N, Laws ER Jr., Peace BB: National survey of patterns of care for brain-tumor patients. J Neurosurg 71: 826–836, 1989Google Scholar
  3. 3.
    CBTRUS (1997): Annual Report. Published by the Central Brain Tumor Registry of the United StatesGoogle Scholar
  4. 4.
    Steele GD, Osteen RT, Winchester DP, Menck HR, Murphy GP (eds): National Cancer Data Base Annual Review of Patient Care 1994. Atlanta: Amer Canc Soc, 1994Google Scholar
  5. 5.
    Steele GD Jr., Jessup JM, Winchester DP, Menck HR, Murphy GP: National Cancer Data Base Annual Review of Patient Care: 1995. Atlanta, Amer Canc Soc, 1995Google Scholar
  6. 6.
    Menck HR, Cunningham MP, Jessup JM, Eyre HJ, Winchester DP, Scott-Conner CEH, Murphy GP: The growth and maturation of the National Cancer Data Base. Cancer 80: 2296–2304, 1997Google Scholar
  7. 7.
    Jessup JM, Menck HR, Winchester DP, Hundahl SA, Murphy GP: The National Cancer Data Base report on patterns of hospital reporting. Cancer 78: 1829–1837, 1996Google Scholar
  8. 8.
    Menck HR, Blakenship C, Fremgen AM: The National Cancer Data Base and physician network. Topics Health Inform Mgt. 17: 45–59, 1997Google Scholar
  9. 9.
    Smart CR, Karnell LH, Eberle C, Zippin C, Lum D, Clive R, Ocwieja KS: Quality control considerations of the National Cancer Data Base. In: Steele GD, Osteen RT, Winchester DP, Menck HR, Murphy GP (eds) National Cancer Data Base Annual Review of Patient Care 1994. Atlanta: American Cancer Society, 1994, pp 117–126Google Scholar
  10. 10.
    Smart CR, Menck HR, Eberle C, Simon S: An assessment of National Cancer Data Base quality control. In: Steele GD, Winchester DP, Menck HR, Murphy GP (eds) National Cancer Data Base Annual Review of Patient Care 1993. Atlanta: American Cancer Society, 1993, pp 103–111Google Scholar
  11. 11.
    Percy C, van Holten V, Muir CM (eds): International Classification of Diseases for Oncology. (2nd, ed.) World Health Organization, Geneva, Switzerland, 1990Google Scholar
  12. 12.
    SAS/STAT User's Guide, Version 6, ed. 4, Cary, NC: SAS Institute, Inc. Volumes 1 and 2, 1988Google Scholar
  13. 13.
    Armitage P, Berry G: Statistical methods in medical research. 2nd. ed., Blackwell Scientific Publications, Oxford. 1987Google Scholar
  14. 14.
    Cox DR: Regression models and life tables. Journal of the Royal Statistical Society, series B, 74: 187–220, 1972Google Scholar
  15. 15.
    Clive HE, Ocwicja KM, Kamell L, Hoyler SS, Seiffert JE, Young JL, Henson DE, Winchester DP, Osteen RT, Menck HR, Fremgen A: A national quality improvement effort: cancer registry data. J Surg Oncol 58: 155–161, 1995Google Scholar
  16. 16.
    Henson DE, Ries LAG: On the estimation of survival. Sem Surg Oncol 10: 2–6, 1994Google Scholar
  17. 17.
    Davis FG, Freels S, Grutsch J, Barlas S, Brem S: Survival of patients with primary malignant brain tumors by age and histologic groupings from Surveillance, Epidemiology, and End Results data (SEER 1973–1991). J Neurosurg 88: 1–10, 1998Google Scholar
  18. 18.
    Burger PC, Green SB: Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer 59: 1617–1625, 1987Google Scholar
  19. 19.
    Winger MJ, Macdonald DR, Cairncross JG: Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg 71: 487–493, 1989Google Scholar
  20. 20.
    Melendon RE, Robinson JS, Chambers DB, Grufferman S, Burger PC: The glioblastoma multiforme in Georgia, 1977–1981. Cancer 65: 894–897, 1985Google Scholar
  21. 21.
    Polednak AP, Flannery JT: Brain, other central nervous system, and eye cancer. Cancer 75: 330–337, 1995Google Scholar
  22. 22.
    Novakovic B: U.S. childhood cancer survival, 1973–1987. Medical and pediatric oncology 23: 480–486, 1994Google Scholar
  23. 23.
    Shugg D, Allen BJ, Blizzard L, Dwyer T, Roder D: Brain cancer incidence, mortality and case survival: observations from two Australian cancer registries. Int J Cancer 59: 765–770, 1994Google Scholar
  24. 24.
    Preston-Martin S, Staples M, Farrugia H, Giles G: Primary tumors of the brain, cranial nerves and cranial meninges in Victoria, Australia, 1982–1990: patterns of incidence and survival. Neuroepidemiology 12: 270–279, 1993Google Scholar
  25. 25.
    Levi F, Va Vecchia C, Te VC: Descriptive epidemiology of malignant brain tumors in the Swiss canton de Vaud. Neuroepidemiology 9: 135–142, 1990Google Scholar
  26. 26.
    Kallio M, Sankila R, Jääskeläinen J, Karalainen S, Hakulinen T: A population-based study on the incidence and survival rates of 3857 glioma patients diagnosed from 1953–1984. Cancer 68: 1394–1400, 1991Google Scholar
  27. 27.
    Sant M, Crosignani P, Bordo BM, Nicola G, Bianchi M, Berrino F: Incidence and survival of brain tumors: a population-based study. Tumori 74: 243–252, 1988Google Scholar
  28. 28.
    Grant R, Liang BC, Page MA, Crane DL, Greenberg HS, Junck L: Age influences chemotherapy response in astrocytomas. Neurology 45: 929–933, 1995Google Scholar
  29. 29.
    Takeuchi K, Sano K, Nomura K: An epidemiological study of brain tumors in the elderly. Neurological Research 13: 21–25, 1991Google Scholar
  30. 30.
    Phuphanich S, Ferrall S, Greenberg H: Long term survival in malignant glioma. J Florida M.A. March 1993 Vol. 80 # 3Google Scholar
  31. 31.
    Ayoubi S, Walter PH, Naik S, Sankaran M, Robinson D: Audit in the management of gliomas. Brit J Neurosurg 1993 (abstract)Google Scholar
  32. 32.
    Hershatter BW, Happerin EC, Cox EB: Medulloblastoma: The Duke University medical center experience. Int J Radiat Oncol Biol Phys 12: 1771–1777, 1986Google Scholar
  33. 33.
    Farwell JR, Dohrmann GJ, Flannery JT: Medulloblastoma in childhood: an epidemiologic study. J Neurosurg 61: 657–664, 1984Google Scholar
  34. 34.
    Mealey J, Hall PV: Medulloblastoma in children. Survival and treatment. J Neurosurg 46: 56–64, 1977Google Scholar
  35. 35.
    Saran FH, Hernaiz-Driever P, Thilmann C, Mose S, Adamietz IA, Bottcher HD: Survival of children with medullo-blastoma treated with craniospinal irradiation — age at presentation as prognostic factor. Jrnl of Neuro-Oncology, 30: 139, 1996. AbstractGoogle Scholar
  36. 36.
    Helseth A: Incidence and survival of intracranial meningioma patients in Norway 1963–1992. Neuroepidemiology 16: 53–59, 1997Google Scholar
  37. 37.
    McCarthy BJ, Davis F, Freels S, Surawiez TS, Damek D, Grutsch J, Menck HR, Laws ER: Factors associated with survival in patients with meningioma. Neurosurg Focus 2(4): 1–8, 1997Google Scholar
  38. 38.
    Winger MJ, Macdonald DR, Schold C, Cairneross JG: Selection bias in clinical trials of anaplastic glioma. Ann of Neurol: 26: 531–534, 1989Google Scholar

Copyright information

© Kluwer Academic Publishers 1998

Authors and Affiliations

  • Tanya S. Surawicz
    • 1
  • Faith Davis
    • 1
  • Sally Freels
    • 1
  • Edward R. LawsJr.
    • 2
  • Herman R. Menck
    • 3
  1. 1.CBTRUS project, Division of Epidemiology and Biostatistics, School of Public HealthUniversity of Illinois at ChicagoChicagoUSA
  2. 2.Department of Neurological SurgeryUniversity of Virginia Health Sciences CenterCharlottesvilleUSA
  3. 3.Clinical Information, National Cancer Data BaseCommission on Cancer of the American College of SurgeonsChicagoUSA

Personalised recommendations